Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 2;6(1):56-65.
doi: 10.1016/j.ekir.2020.10.020. eCollection 2021 Jan.

A Systematic Review of the Incidence of Arrhythmias in Hemodialysis Patients Undergoing Long-Term Monitoring With Implantable Loop Recorders

Affiliations

A Systematic Review of the Incidence of Arrhythmias in Hemodialysis Patients Undergoing Long-Term Monitoring With Implantable Loop Recorders

Paul R Roberts et al. Kidney Int Rep. .

Abstract

Introduction: Establishing the frequency and nature of arrhythmias in hemodialysis (HD) is an important step in improving outcomes of these patients. We undertook this systematic review and meta-analysis to characterize arrhythmia frequency in maintenance HD patients.

Methods: We identified studies on arrhythmias in adult patients on maintenance HD detected via implantable loop recorders (ILRs). Studies included were in English and reported ILR-detected arrhythmia incidence in HD patients. Data were extracted by one author using electronic spreadsheets and verified by a second author. Random effects models were used for pooled inferences. The I 2 statistic was used to quantify heterogeneity.

Results: Five studies qualified for inclusion (317 patients). The overall estimates for the annualized rate of death and sudden cardiac death (SCD) was 0.14 (95% confidence interval [CI]: 0.11-0.18) and 0.06 (95% CI: 0.03-0.10), respectively. Across all 5 studies, the combined annualized rate of patients experiencing at least 1 bradycardia/asystole event was 0.19 (95% CI: 0.11-0.33) but heterogeneity was high (I 2 = 79.8%). The average annualized rate of sustained ventricular tachycardia (VT) or ventricular fibrillation (VF) episodes (0.02, 95% CI: 0.01-0.05) was significantly lower (P < 0.001) than the rate of bradycardia/asystole reported in the same patients. Incidence of atrial fibrillation (AF) varied significantly across the studies (from 0.07 to 0.83 patients per year) reflecting variable definitions (new-onset vs. total number of episodes).

Conclusion: The incidence of arrhythmias among chronic HD patients is high, with bradycardia/asystole occurring more frequently than ventricular arrhythmias. Additional studies to refine estimates particularly of AF are needed.

Keywords: asystole; bradycardia; hemodialysis; implantable loop recorder; sudden cardiac death.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1
Figure 1
Publication selection.
Figure 2
Figure 2
Annualized death rate for any cause pooled across studies. Vertical line indicates pooled estimate across studies. FUP, follow-up.
Figure 3
Figure 3
Annualized sudden cardiac death rate pooled across studies. Vertical line indicates pooled estimate across studies. FUP, follow-up; SCD, sudden cardiac death.
Figure 4
Figure 4
Annualized rate of arrhythmias by arrhythmia type pooled across studies. Vertical line indicates pooled estimate across studies. FUP, follow-up; VF, ventricular fibrillation; VT, ventricular tachycardia.
Figure 5
Figure 5
Annualized rate of atrial fibrillation (AF) pooled across studies by arrhythmia type pooled across studies. Top panel: new-onset AF. Bottom panel: new or recurrent any AF identified by implantable loop recorder (ILR). The study by Roberts et al. provided data only for new-onset AF. The study by Silva et al. provided data only for all ILR-detected AF and did not clearly distinguish between de novo and recurrent AF. FUP, follow-up.

References

    1. US Renal Data System . National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda, MD: 2018. USRDS 2018 Annual Data Report: Atlas of End-Stage Renal Disease in the United States.
    1. Evolve Trial Investigators. Chertow G.M., Block G.A. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med. 2012;367:2482–2494. - PubMed
    1. Wanner C., Krane V., Marz W. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353:238–248. - PubMed
    1. Weiner D.E., Tighiouart H., Elsayed E.F. The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol. 2007;50:217–224. - PubMed
    1. Himmelfarb J., Stenvinkel P., Ikizler T.A. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002;62:1524–1538. - PubMed

LinkOut - more resources